Resumen de acción POLYMED
Poly Medicure Limited fabrica y vende productos sanitarios en la India y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Competidores de Poly Medicure Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,802.25 |
| 52 Week High | ₹1,925.60 |
| 52 Week Low | ₹963.00 |
| Beta | 0.34 |
| 1 Month Change | 7.05% |
| 3 Month Change | 12.64% |
| 1 Year Change | 86.15% |
| 3 Year Change | 77.48% |
| 5 Year Change | 846.56% |
| Change since IPO | 4,919.32% |
Noticias y actualizaciones recientes
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Recent updates
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return
Mar 01I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease
Feb 16How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?
Feb 01Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?
Jan 17Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?
Dec 09
Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years
Nov 24Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?
Nov 09Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital
Oct 26Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?
Oct 06Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?
Sep 17Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?
Sep 02Rentabilidad de los accionistas
| POLYMED | IN Medical Equipment | Mercado IN | |
|---|---|---|---|
| 7D | -0.3% | 0.5% | -1.9% |
| 1Y | 86.2% | 74.9% | 41.0% |
Rentabilidad vs. Industria: POLYMED superó al sector Indian Medical Equipment , que obtuvo un rendimiento del 60.7% el año pasado.
Rentabilidad vs. Mercado: POLYMED superó al mercado Indian, que obtuvo un rendimiento del 45% el año pasado.
Volatilidad de los precios
| POLYMED volatility | |
|---|---|
| POLYMED Average Weekly Movement | 4.1% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: POLYMED no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de POLYMED (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1995 | 2,339 | Himanshu Baid | www.polymedicure.com |
Poly Medicure Limited fabrica y vende dispositivos médicos en la India y a escala internacional. Ofrece dispositivos de infusión, como cánulas intravenosas, catéteres de línea media, cánulas arteriales, llaves de tres vías, equipos de infusión intravenosa, colectores, equipos de infusión con alas de seguridad, equipos de extensión tipo T, estilete/mandril con cierres luer, picos de acceso a viales, equipos de administración de fluidos de volumen medido, líneas de extensión, catéteres venosos centrales, manómetros de presión venosa central, conectores sin aguja, jeringas precargadas, accesos vasculares y equipos de administración de sangre. La empresa también suministra sondas nasogástricas y de alimentación infantil, sondas de alimentación gastroduodenal y catéteres umbilicales; bolsas de recogida de orina, catéteres de balón de Foley, sets de irrigación, catéteres de drenaje de orina y bolsas de recogida de orina con medidores de volumen medido; y sondas endotraqueales y de traqueostomía, extractores de moco, circuitos de ventilación, circuitos de baño, soportes de catéter, agujas espinales, filtros HME y máscaras laríngeas.
Resumen de fundamentos de Poly Medicure Limited
| Estadísticas fundamentales de POLYMED | |
|---|---|
| Capitalización bursátil | ₹173.48b |
| Beneficios(TTM) | ₹2.58b |
| Ingresos (TTM) | ₹13.76b |
67.2x
Ratio precio-beneficio (PE)12.6x
Ratio precio-ventas (PS)¿Está POLYMED sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de POLYMED | |
|---|---|
| Ingresos | ₹13.76b |
| Coste de los ingresos | ₹4.83b |
| Beneficio bruto | ₹8.93b |
| Otros gastos | ₹6.35b |
| Beneficios | ₹2.58b |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 26.91 |
| Margen bruto | 64.92% |
| Margen de beneficio neto | 18.77% |
| Ratio deuda/patrimonio | 11.6% |
¿Cómo se ha desempeñado POLYMED a largo plazo?
Ver rendimiento histórico y comparativa